Wearable Device-Assisted Remote Management to Improve Prognosis in Patients With Acute Heart Failure Complicated by Atrial Fibrillation: WARM-HF Trial (Stage 2)

NCT07687862 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

818

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation (AF)
Heart Failure and Reduced Ejection Fraction

Interventions

DRUG: wearable device based remote management (GDMT titration for HF, rhythm control and anticoagulation management for AF)

Sponsor

Beijing Anzhen Hospital